| Dedifferentiated chondrocytes cultured in alginate beads: Restoration of the differentiated phenotype and of the metabolic responses to Interleukin‐1β F Lemare, N Steimberg, C Le Griel, S Demignot, M Adolphe Journal of cellular physiology 176 (2), 303-313, 1998 | 191 | 1998 |
| Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer A Thomas-Schoemann, F Batteux, C Mongaret, C Nicco, C Chéreau, ... The Journal of Immunology 189 (11), 5171-5177, 2012 | 103 | 2012 |
| High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer O Mir, S Ropert, J Alexandre, F Lemare, F Goldwasser Annals of oncology 19 (11), 1978-1980, 2008 | 92 | 2008 |
| Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial O Mir, M Ferrua, A Fourcade, D Mathivon, A Duflot-Boukobza, S Dumont, ... Nature Medicine 28 (6), 1224-1231, 2022 | 58 | 2022 |
| Restoration of the differentiated functions of serially passaged chondrocytes using staurosporine L Borge, F Lemare, S Demignot, M Adolphe In Vitro Cellular & Developmental Biology-Animal 33, 703-709, 1997 | 37 | 1997 |
| Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC P Roy, C Canet-Jourdan, M Annereau, O Zajac, M Gelli, S Broutin, ... International journal of pharmaceutics 531 (1), 143-152, 2017 | 30 | 2017 |
| The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial A Pagès, S Foulon, Z Zou, L Lacroix, F Lemare, T De Baère, C Massard, ... Genetics in Medicine 19 (6), 683-690, 2017 | 30 | 2017 |
| Intervention combining Nurse Navigators (NNs) and a mobile application vs. standard of care (SOC) in cancer patients (pts) treated with oral anticancer agents (OAA): results of … O Mir, M Ferrua, A Fourcade, D Mathivon, A Duflot-Boukobza, SN Dumont, ... ASCO 2020 annual meeting 38 (suppl. ASCO Annual Meeting), abstract 2000, 2020 | 29 | 2020 |
| Cyclosporine 2% eye drops preparation F Chast, F Lemare, JM Legeais, R Batista, C Bardin, G Renard Journal Francais D'ophtalmologie 27 (6 Pt 1), 567-576, 2004 | 29* | 2004 |
| Impacts of a navigation program based on health information technology for patients receiving oral anticancer therapy: the CAPRI randomized controlled trial C Gervès-Pinquié, F Daumas-Yatim, B Lalloué, A Girault, M Ferrua, ... BMC health services research 17, 1-8, 2017 | 25 | 2017 |
| Physico-chemical stability of busulfan in injectable solutions in various administration packages M Houot, V Poinsignon, L Mercier, C Valade, R Desmaris, F Lemare, ... Drugs in R&D 13, 87-94, 2013 | 25 | 2013 |
| Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form C Mongaret, J Alexandre, A Thomas‐Schoemann, E Bermudez, ... International journal of cancer 129 (4), 791-798, 2011 | 25 | 2011 |
| Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool G Hébert, F Netzer, M Ferrua, M Ducreux, F Lemare, E Minvielle European Journal of Cancer 51 (3), 427-435, 2015 | 23 | 2015 |
| Use of antioxidant and other complementary medicine by patients treated by antitumor chemotherapy: a prospective study A Thomas-Schoemann, J Alexandre, C Mongaret, S Azibi, A Dauphin, ... Bulletin Du Cancer 98 (6), 645-653, 2011 | 23* | 2011 |
| 5-Azacitidine in patients with IDH1/2-mutant recurrent glioma L Federici, L Capelle, M Annereau, F Bielle, C Willekens, C Dehais, ... Neuro-oncology 22 (8), 1226-1228, 2020 | 18 | 2020 |
| Bystander effect of vinorelbine alters antitumor immune response A Thomas‐Schoemann, F Lemare, C Mongaret, E Bermudez, C Chéreau, ... International journal of cancer 129 (6), 1511-1518, 2011 | 15 | 2011 |
| High-dose thiotepa-related neurotoxicity and the role of tramadol in children C Maritaz, F Lemare, A Laplanche, S Demirdjian, D Valteau-Couanet, ... BMC cancer 18, 1-9, 2018 | 13 | 2018 |
| Computerized pediatric oncology prescriptions review by pharmacist: A descriptive analysis and associated risk factors C Hamel, L Tortolano, E Bermudez, R Desmaris, S Klein, F Slimano, ... Pediatric Blood & Cancer 65 (4), e26897, 2018 | 13 | 2018 |
| High incidence of cetuximab-related infusion reactions in head and neck patients VP Coloma, P Bravo, N Lezghed, L Mayache-Badis, RGH Gómez, ... ESMO open 3 (5), e000346, 2018 | 11 | 2018 |
| ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype CM Kossmann, M Annereau, A Thomas-Schoemann, C Nicco-Overney, ... Tumor Biology 39 (7), 1010428317716077, 2017 | 11 | 2017 |
Jérôme AlexandreUniversité Paris CitéVerified email at aphp.fr
